buprenorphine
buprenorphine is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including SUBLOCADE, buprenorphine transdermal system, Butrans. Available dosage forms: solution, patch, extended release.
Drug details
- Generic Name
- buprenorphine
- Brand Names
- SUBLOCADE, buprenorphine transdermal system, Butrans
- Application Number
- NDA209819
- Sponsor
- Indivior Inc.
- NDC Codes
- 18
- Dosage Forms
- SOLUTION, PATCH, EXTENDED RELEASE
- Routes
- SUBCUTANEOUS, TRANSDERMAL
- Active Ingredients
- BUPRENORPHINE
Indications and Usage
1 INDICATIONS AND USAGE SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support. SUBLOCADE contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. ( 1 ) SUBLOCADE should be used as part of a complete treatment program that includes counseling and psychosocial support. ( 1 )